Citations

Citations to this article as recorded by  

• Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies
  Samuel Igweokpala, Naheemot Olaoluwa Sule, Antonios Douros, Oriana H. Y. Yu, Kristian B. Filion
  Diabetes, Obesity and Metabolism.2024; 26(2): 721.     CrossRef
• Association of sodium–glucose cotransporter‐2 inhibitors and the risk of retinal vascular occlusion: A real‐world retrospective cohort study in Taiwan
  Tzu‐Yi Lin, Eugene Yu‐Chuan Kang, Shih‐Chieh Shao, Edward Chia‐Cheng Lai, Nan‐Kai Wang, Sunir J. Garg, Kuan‐Jen Chen, Je‐Ho Kang, Wei‐Chi Wu, Chi‐Chun Lai, Yih‐Shiou Hwang
  Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
• Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study
  Yu-Chi Su, Pei-Chun Hsieh, Edward Chia-Cheng Lai, Yu-Ching Lin
  Diabetes & Metabolism.2024; 50(2): 101522.     CrossRef
• Optimising renal risk parameters in type 2 diabetes mellitus: Perspectives from a retinal viewpoint
  Sarita Jacob, George I. Varughese
  Clinical Medicine.2024; 24(2): 100031.     CrossRef
• Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database
  Aikaterini Eleftheriadou, David Riley, Sizheng S. Zhao, Philip Austin, Gema Hernández, Gregory Y. H. Lip, Timothy L. Jackson, John P. H. Wilding, Uazman Alam
  Diabetologia.2024;[Epub]     CrossRef
• Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study
  Karen M. Wai, Kapil Mishra, Euna Koo, Cassie Ann Ludwig, Ravi Parikh, Prithvi Mruthyunjaya, Ehsan Rahimy
  American Journal of Ophthalmology.2024;[Epub]     CrossRef
• Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
  Tzu-Yi Lin, Eugene Yu-Chuan Kang, Shih-Chieh Shao, Edward Chia-Cheng Lai, Yih-Shiou Hwang
  Diabetes & Metabolism Journal.2023; 47(4): 573.     CrossRef
• Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
  Jihee Ko, Sun Joon Moon
  Diabetes & Metabolism Journal.2023; 47(4): 571.     CrossRef
• Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinopathy in Patients With Type 2 Diabetes
  Fu-Shun Yen, James Cheng-Chung Wei, Teng-Shun Yu, Yu-Tung Hung, Chih-Cheng Hsu, Chii-Min Hwu
  JAMA Network Open.2023; 6(12): e2348431.     CrossRef

Citations

Citations to this article as recorded by  

• Liraglutide does not increase heart rate of diabetic patients during acute myocardial infarction
  Qianyi Li, Chunxuan Wu, Shiqun Sun, Lingchao Yang, Yanyan Li, Yixin Niu, Li Zhang, Wei Li, Ying Yu
  Journal of Diabetes.2024;[Epub]     CrossRef
• Hormonal Gut–Brain Signaling for the Treatment of Obesity
  Eun Roh, Kyung Mook Choi
  International Journal of Molecular Sciences.2023; 24(4): 3384.     CrossRef
• Effects of new hypoglycemic drugs on cardiac remodeling: a systematic review and network meta-analysis
  Yi-lin Huang, Xiao-zhuo Xu, Jing Liu, Pin-yao Wang, Xue-li Wang, Hong-lin Feng, Cheng-jiang Liu, Xu Han
  BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
• Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023
  Tiffany Lowe Clayton, Angela Fitch, Harold Edward Bays
  Obesity Pillars.2023; 8: 100083.     CrossRef
• Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
  Jonathan Goldney, Jack A. Sargeant, Melanie J. Davies
  Diabetologia.2023; 66(10): 1832.     CrossRef
• Diabetes-Induced Cardiac Autonomic Neuropathy: Impact on Heart Function and Prognosis
  Susumu Z. Sudo, Tadeu L. Montagnoli, Bruna de S. Rocha, Aimeé D. Santos, Mauro P. L. de Sá, Gisele Zapata-Sudo
  Biomedicines.2022; 10(12): 3258.     CrossRef

Citations

Citations to this article as recorded by  

• Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies
  Aftab Ahmad, Hani Sabbour
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• Hormonal Gut–Brain Signaling for the Treatment of Obesity
  Eun Roh, Kyung Mook Choi
  International Journal of Molecular Sciences.2023; 24(4): 3384.     CrossRef
• All‐cause mortality and cardiovascular outcomes with sodium‐glucose Co‐transporter 2 inhibitors, glucagon‐like peptide‐1 receptor agonists and with combination therapy in people with type 2 diabetes
  David R. Riley, Hani Essa, Philip Austin, Frank Preston, Isatu Kargbo, Gema Hernández Ibarburu, Ramandeep Ghuman, Daniel J. Cuthbertson, Gregory Y. H. Lip, Uazman Alam
  Diabetes, Obesity and Metabolism.2023; 25(10): 2897.     CrossRef
• The Efficacy and Safety of the Combination Therapy With GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
  Chen Li, Jie Luo, Mingyan Jiang, Keke Wang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
  Hwi Seung Kim, Woo Je Lee
  Diabetes & Metabolism Journal.2022; 46(4): 665.     CrossRef
• Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
  Tomoyuki Kawada
  Diabetes & Metabolism Journal.2022; 46(4): 663.     CrossRef
• Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study
  Hwi Seung Kim, Yun Kyung Cho, Myung Jin Kim, Chang Hee Jung, Joong-Yeol Park, Woo Je Lee
  Frontiers in Endocrinology.2022;[Epub]     CrossRef

The burden of diabetic cardiovascular autonomic neuropathy (CAN) is expected to increase due to the diabetes epidemic and its early and widespread appearance. CAN has a definite prognostic role for mortality and cardiovascular morbidity. Putative mechanisms for this are tachycardia, QT interval prolongation, orthostatic hypotension, reverse dipping, and impaired heart rate variability, while emerging mechanisms like inflammation support the pervasiveness of autonomic dysfunction. Efforts to overcome CAN under-diagnosis are on the table: by promoting screening for symptoms and signs; by simplifying cardiovascular reflex tests; and by selecting the candidates for screening. CAN assessment allows for treatment of its manifestations, cardiovascular risk stratification, and tailoring therapeutic targets. Risk factors for CAN are mainly glycaemic control in type 1 diabetes mellitus (T1DM) and, in addition, hypertension, dyslipidaemia, and obesity in type 2 diabetes mellitus (T2DM), while preliminary data regard glycaemic variability, vitamin B12 and D changes, oxidative stress, inflammation, and genetic biomarkers. Glycaemic control prevents CAN in T1DM, whereas multifactorial intervention might be effective in T2DM. Lifestyle intervention improves autonomic function mostly in pre-diabetes. While there is no conclusive evidence for a disease-modifying therapy, treatment of CAN manifestations is available. The modulation of autonomic function by SGLT2i represents a promising research field with possible clinical relevance.

Citations

Citations to this article as recorded by  

• Rectal sensitivity correlated with gastrointestinal‐mediated glucose disposal, but not the incretin effect
  Sondre Meling, Erling Tjora, Heike Eichele, Rasmus B. Nedergaard, Filip K. Knop, Niels Ejskjaer, Siri Carlsen, Pål R. Njølstad, Christina Brock, Eirik Søfteland
  Endocrinology, Diabetes & Metabolism.2024;[Epub]     CrossRef
• Glucose metabolism and autonomic function in healthy individuals and patients with type 2 diabetes mellitus at rest and during exercise
  Takuto Hamaoka, Urs A. Leuenberger, Rachel C. Drew, Matthew Murray, Cheryl Blaha, Jonathan Carter Luck, Lawrence I. Sinoway, Jian Cui
  Experimental Physiology.2024; 109(2): 214.     CrossRef
• Quantification of lipoproteins by proton nuclear magnetic resonance spectroscopy (1H-NMRS) improves the prediction of cardiac autonomic dysfunction in patients with type 1 diabetes
  L. Nattero-Chávez, M. Insenser, N. Amigó, S. Samino, N. Martínez-Micaelo, B. Dorado Avendaño, A. Quintero Tobar, H. F. Escobar-Morreale, M. Luque-Ramírez
  Journal of Endocrinological Investigation.2024;[Epub]     CrossRef
• Predictors of pacemaker requirement in patients with implantable loop recorder and unexplained syncope: A systematic review and meta‐analysis
  Moein Zangiabadian, Kiarash Soltani, Yasaman Gholinejad, Reyhane Yahya, Shayan Bastami, Mohammad Ali Akbarzadeh, Mohammad Sharifian Ardestani, Azadeh Aletaha
  Clinical Cardiology.2024;[Epub]     CrossRef
• No clear evidence of neuropathy among patients with high risk for the development of prediabetes/diabetes—a pilot study
  Anna E. Körei, Magdolna Békeffy, Adrienn Menyhárt, Karola Osgyán, Ildikó Istenes, Viktor J. Horváth, Péter Kempler
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Effects of Physical Cues on Stem Cell-Derived Extracellular Vesicles toward Neuropathy Applications
  Danyale Berry, Justice Ene, Aakash Nathani, Mandip Singh, Yan Li, Changchun Zeng
  Biomedicines.2024; 12(3): 489.     CrossRef
• Oxidative stress, endothelial dysfunction, and N-acetylcysteine in type-2 diabetes mellitus
  Xin Li, Junyong Zou, Aiping Lin, Jingshu Chi, Hong Hao, Hong Chen, Zhenguo Liu
  Antioxidants & Redox Signaling.2024;[Epub]     CrossRef
• High dose cholecalciferol supplementation causing morning blood pressure reduction in patients with type 1 diabetes mellitus and cardiovascular autonomic neuropathy
  João Felício, Lorena Moraes, Gabriela Lemos, Ícaro Souza, Giovana Vieira, Lilian Silva, Natércia Queiroz, Ana Carolina Souza, Franciane Melo, João Felício Abrahão Neto, Hana Britto, Manuela Lemos, Márcia Santos, Priscila Figueiredo, Ana Regina Motta, Meli
  Scientific Reports.2024;[Epub]     CrossRef
• Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial
  Ditte S. Kornum, Davide Bertoli, Huda Kufaishi, Anne-Marie Wegeberg, Tina Okdahl, Esben B. Mark, Katrine L. Høyer, Jens B. Frøkjær, Birgitte Brock, Klaus Krogh, Christian S. Hansen, Filip K. Knop, Christina Brock, Asbjørn M. Drewes
  Diabetologia.2024;[Epub]     CrossRef
• Independent and interactive associations of heart rate and obesity with type 2 diabetes mellites: A population‐based study
  Tianxin Zhu, Qingyu Chen, Hongxing Chen, Lili You, Dan Liu, Xiaoyun Zhang, Feng Li, Hongshi Wu, Juying Tang, Diaozhu Lin, Kan Sun, Li Yan, Meng Ren
  Journal of Diabetes.2024;[Epub]     CrossRef
• Mortality risk factors in newly diagnosed diabetic cardiac autonomic neuropathy
  Bruce A. Chase, Sylwia Pocica, Roberta Frigerio, Katerina Markopoulou, Demetrius M. Maraganore, Navamon Aunaetitrakul, Alexander Epshteyn, Alexandru C. Barboi
  Clinical Autonomic Research.2023; 33(6): 903.     CrossRef
• Autonomic symptoms and associated factors in patients with chronic heart failure
  Hellen Da Silva, Sofie Pardaens, Marc Vanderheyden, Johan De Sutter, Heleen Demeyer, Michel De Pauw, Laurent Demulier, Jan Stautemas, Patrick Calders
  Acta Cardiologica.2023; 78(2): 203.     CrossRef
• Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
  Jonathan Goldney, Jack A. Sargeant, Melanie J. Davies
  Diabetologia.2023; 66(10): 1832.     CrossRef
• Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings
  Eleonora Galosi, Luca Leonardi, Pietro Falco, Giuseppe Di Pietro, Alessandra Fasolino, Nicoletta Esposito, Caterina Leone, Giulia Di Stefano, Maurizio Inghilleri, Marco Luigetti, Antonini Giovanni, Andrea Truini
  Amyloid.2023; 30(1): 59.     CrossRef
• In vivo molecular imaging of cardiac angiogenesis in persons with and without type 2 diabetes: A cross‐sectional 68 Ga‐RGD‐PET study
  Jens Christian Laursen, Ida Kirstine Bull Rasmussen, Emilie Hein Zobel, Philip Hasbak, Lene Holmvang, Christian Stevns Hansen, Bernt Johan von Scholten, Marie Frimodt‐Møller, Peter Rossing, Tine Willum Hansen, Andreas Kjaer, Rasmus Sejersten Ripa
  Diabetic Medicine.2023;[Epub]     CrossRef
• Cardiac innervations in diabetes mellitus—Anatomical evidence of neuropathy
  Natalija Filipović, Maja Marinović Guić, Vana Košta, Katarina Vukojević
  The Anatomical Record.2023; 306(9): 2345.     CrossRef
• Clinical Predictors of Pacing Device Implantation in Implantable Cardiac Monitor Recipients for Unexplained Syncope
  Reina Tonegawa-Kuji, Yuko Y. Inoue, Michikazu Nakai, Koshiro Kanaoka, Yoko Sumita, Yuichiro Miyazaki, Akinori Wakamiya, Keiko Shimamoto, Nobuhiko Ueda, Kenzaburo Nakajima, Naoya Kataoka, Mitsuru Wada, Kenichiro Yamagata, Kohei Ishibashi, Koji Miyamoto, Sa
  CJC Open.2023; 5(4): 259.     CrossRef
• Cardiovascular autonomic reflex tests using a handheld device in the diagnosis of cardiovascular autonomic neuropathy in patients with schizophrenia
  Laura Blok-Husum, Milka Ane Rank Brcelic, Hanin Kawa Farman Kawal Bassi, Svend Eggert Jensen, Rene Ernst Nielsen, Kristian Kragholm, Jesper Fleischer, Esben Laugesen, Christoffer Polcwiartek
  American Heart Journal Plus: Cardiology Research and Practice.2023; 26: 100252.     CrossRef
• Causal association between vitamin D and diabetic neuropathy: a Mendelian randomization analysis
  Wei Huang, Lei Gu, Jingwen Wang, Yiqi Wang, Fangzheng Cao, Tianyu Jin, Yifan Cheng
  Endocrine.2023; 80(2): 328.     CrossRef
• Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
  Panagiotis Theofilis, Evangelos Oikonomou, Konstantinos Tsioufis, Dimitris Tousoulis
  Life.2023; 13(2): 497.     CrossRef
• Sex differences and sex steroids influence on the presentation and severity of cardiovascular autonomic neuropathy of patients with type 1 diabetes
  Lía Nattero-Chávez, María Insenser, Alejandra Quintero Tobar, Elena Fernández-Durán, Beatriz Dorado Avendaño, Tom Fiers, Jean-Marc Kaufman, Manuel Luque-Ramírez, Héctor F. Escobar-Morreale
  Cardiovascular Diabetology.2023;[Epub]     CrossRef
• Early Gastrointestinal Neuropathy Assessed by Wireless Motility Capsules in Adolescents with Type 1 Diabetes
  Vinni Faber Rasmussen, Mathilde Thrysøe, Páll Karlsson, Esben Thyssen Vestergaard, Kurt Kristensen, Ann-Margrethe Rønholt Christensen, Jens Randel Nyengaard, Astrid Juhl Terkelsen, Christina Brock, Klaus Krogh
  Journal of Clinical Medicine.2023; 12(5): 1925.     CrossRef
• Heart rate variability in people with metabolic syndrome
  Kostiantyn Apykhtin, Svitlana Drozdovska, Olha Hurenko, Anastasiia Nahorna, Anatoly Pisaruk, Yuliia Panchenko, Olena Andrieieva
  Ageing & Longevity.2023; (1 2023): 1.     CrossRef
• Heart rate variability in people with metabolic syndrome
  Kostiantyn Apykhtin, Svitlana Drozdovska, Olha Hurenko, Anastasiia Nahorna, Anatoly Pisaruk, Yuliia Panchenko, Olena Andrieieva
  JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE.2023; (1 2023): 1.     CrossRef
• Potential of electronic devices for detection of health problems in older adults at home: A systematic review and meta-analysis
  Yu-ting Cao, Xin-xin Zhao, Yi-ting Yang, Shi-jie Zhu, Liang-dong Zheng, Ting Ying, Zhou Sha, Rui Zhu, Tao Wu
  Geriatric Nursing.2023; 51: 54.     CrossRef
• Diabetes mellitus in der Akut- und Notfallmedizin
  Leo Benning, Julian Krehl, Felix Patricius Hans
  Notfallmedizin up2date.2023; 18(01): 45.     CrossRef
• Correlation between Heart rate recovery and Left Atrial phasic functions evaluated by 2D speckle-tracking Echocardiography after Acute Myocardial infarction
  Behruz Mashayekhi, Reza Mohseni-Badalabadi, Ali Hosseinsabet, Tahereh Ahmadian
  BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
• Pancreatic sympathetic innervation disturbance in type 1 diabetes
  Senlin Li, Huimin Yuan, Keshan Yang, Qing Li, Ming Xiang
  Clinical Immunology.2023; 250: 109319.     CrossRef
• A Nonrandomized Trial of the Effects of Passive Simulated Jogging on Short-Term Heart Rate Variability in Type 2 Diabetic Subjects
  Jose A. Adams, Jose R. Lopez, Veronica Banderas, Marvin A. Sackner, Mark Yorek
  Journal of Diabetes Research.2023; 2023: 1.     CrossRef
• Evaluating treatment options for cardiovascular autonomic neuropathy in patients with diabetes mellitus: a systematic review
  Jasmine KaiLi Goh, Leroy Koh
  Diabetology International.2023; 14(3): 224.     CrossRef
• Autonomic neuropathic symptoms in patients with diabetes: practical tools for screening in daily routine
  Ana Raquel Souza de Azevedo Vieira, Lara Benigno Porto-Dantas, Flaviene Alves do Prado Romani, Patrícia Souza Carvalho, Rodica Pop-Busui, Hermelinda Cordeiro Pedrosa
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• “Arterial stiffness is not associated with changes in the circadian pattern of blood pressure in patients with type 1 diabetes mellitus and cardiovascular autonomic dysfunction”
  Lía Nattero-Chávez, Ane Bayona Cebada, Elena Fernández-Durán, Alejandra Quintero Tobar, Beatriz Dorado Avendaño, Héctor Escobar-Morreale, Manuel Luque-Ramírez
  Diabetes and Vascular Disease Research.2023; 20(3): 147916412311736.     CrossRef
• Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN)
  Sanjeev Sharma, Gerry Rayman
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum
  Jens Faber, Søren Ballegaard, Nanna Ørsted, Ebbe Eldrup, Benny Karpatschof, Finn Gyntelberg, Sofie Korsgaard Hecquet, Albert Gjedde
  Frontiers in Neuroscience.2023;[Epub]     CrossRef
• Functional status associated with postural dizziness, but not postural hypotension, in older adults: a community-based study
  Hsiang-Ju Cheng, Zih-Jie Sun, Feng-Hwa Lu, Yi-Ching Yang, Chih-Jen Chang, Jin-Shang Wu
  BMC Geriatrics.2023;[Epub]     CrossRef
• Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open‐label, crossover trial
  Jens Christian Laursen, Viktor Rotbain Curovic, Marjolein Y. A. M. Kroonen, Niels Jongs, Emilie H. Zobel, Tine W. Hansen, Marie Frimodt‐Møller, Gozewijn D. Laverman, Adriaan Kooy, Frederik Persson, Hiddo J. L. Heerspink, Christian Stevns Hansen, Peter Ros
  Diabetes, Obesity and Metabolism.2023; 25(10): 3064.     CrossRef
• The Retinal Nerve Fiber Layer Thickness Is Associated with Systemic Neurodegeneration in Long-Term Type 1 Diabetes
  Christina Brock, Anne-Marie Wegeberg, Thomas Arendt Nielsen, Bassam Karout, Per M. Hellström, Asbjørn Mohr Drewes, Henrik Vorum
  Translational Vision Science & Technology.2023; 12(6): 23.     CrossRef
• The Use of Empirical Mode Decomposition on Heart Rate Variability Signals to Assess Autonomic Neuropathy Progression in Type 2 Diabetes
  Sandra Cossul, Felipe Rettore Andreis, Mateus Andre Favretto, Jefferson Luiz Brum Marques
  Applied Sciences.2023; 13(13): 7824.     CrossRef
• Topical capsaicin for the management of painful diabetic neuropathy: a narrative systematic review
  Brandon Goodwin, Maanas Chiplunkar, Ryan Salerno, Kylon Coombs, Umar Sannoh, Vrushank Shah, Nicholas Averell, Usmaan Al-Shebab, Deanna Janora
  Pain Management.2023; 13(5): 309.     CrossRef
• Adynamic response to cold pain reflects dysautonomia in type 1 diabetes and polyneuropathy
  Thomas Arendt Nielsen, Søren Lundbye-Christensen, Yoanna Krasimirova Dimitrova, Sam Riahi, Birgitte Brock, Asbjørn Mohr Drewes, Christina Brock
  Scientific Reports.2023;[Epub]     CrossRef
• Autonomic Nerve Function Tests in Patients with Diabetes
  Heung Yong Jin, Tae Sun Park
  The Journal of Korean Diabetes.2023; 24(2): 71.     CrossRef
• Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies
  Mandeep Kaur, Sakshi Misra, Priyanka Swarnkar, Preeti Patel, Balak Das Kurmi, Ghanshyam Das Gupta, Amrita Singh
  Biochemical Pharmacology.2023; 215: 115723.     CrossRef
• A three-month physical training program improves cardiovascular autonomic function in patients with metabolic syndrome with and without diabetes – a pilot study
  Anna Vágvölgyi, Judit Erzsébet Ábrahám, Éva Máthéné Köteles, Andrea Korom, Mária Barnai, Mónika Szűcs, Andrea Orosz, Péter Kempler, Adrienn Menyhárt, Attila Nemes, Tamás Várkonyi, István Baczkó, István Kósa, Csaba Lengyel
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Cardiovascular autonomic neuropathy in patients with type 2 diabetes with and without sensorimotor polyneuropathy
  Emil Peters, Mustapha Itani, Alexander G. Kristensen, Astrid Juhl Terkelsen, Thomas Krøigård, Hatice Tankisi, Troels S. Jensen, Nanna B. Finnerup, Sandra Sif Gylfadottir
  Journal of the Peripheral Nervous System.2023; 28(3): 450.     CrossRef
• Cardiac Autonomic Neuropathy in Prediabetes: A Case-Control Study
  Pavan Gujjar, Y. S. Ravikumar, Lakshmi Nagendra, Hiya Boro, Saptarshi Bhattacharya
  Indian Journal of Endocrinology and Metabolism.2023; 27(4): 325.     CrossRef
• Diabetic Neuropathies
  Melissa A. Elafros, Brian C. Callaghan
  CONTINUUM: Lifelong Learning in Neurology.2023; 29(5): 1401.     CrossRef
• Determinants of the heart rate variability in type 1 diabetes mellitus
  Máté Hajdu, Konstandia Garmpis, Vivien Vértes, Noémi Vorobcsuk-Varga, Gergő Attila Molnár, László Hejjel, István Wittmann, Réka Faludi
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• The Effect of Exercise on Cardiovascular Autonomic Nervous Function in Patients with Diabetes: A Systematic Review
  Hidetaka Hamasaki
  Healthcare.2023; 11(19): 2668.     CrossRef
• Influence of Fibrinogen/Albumin Ratio and Fibrinogen/Pre-Albumin Ratio on Cardiac Autonomic Neuropathy in Type 2 Diabetes
  Subei Zhao, Zheng Yang, Meng Yu, Linyu Xiang, Yuhuan Lv, Chunyan Tian, Rong Li
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 3249.     CrossRef
• In Ischemic Heart Disease, Reduced Sensitivity to Pressure at the Sternum Accompanies Lower Mortality after Five Years: Evidence from a Randomized Controlled Trial
  Søren Ballegaard, Jens Faber, Christian Selmer, Finn Gyntelberg, Svend Kreiner, Benny Karpatschof, Tobias Wirenfeldt Klausen, Åke Hjalmarson, Albert Gjedde
  Journal of Clinical Medicine.2023; 12(24): 7585.     CrossRef
• Assessment of the relationship of systemic vascular dysfunction and cardiac autonomic neuropathy (CAN) with diabetic retinopathy
  KJ Hari Prakash, Sucheta Parija, Manisha Kar
  Journal of Family Medicine and Primary Care.2023; 12(12): 3236.     CrossRef
• Autonomic Neuropathy in Ambulatory Type 2 Diabetes Mellitus Patients: A Single-arm Prospective, Observational Study
  Kaustav Saha, Shatavisa Mukherjee, Animesh Maiti, Santanu Kumar Tripathi
  Journal of the Practice of Cardiovascular Sciences.2023; 9(3): 178.     CrossRef
• Insomnia and type 2 diabetes: how to help the patient. Modern view of a neurologist
  E. S. Akarachkova, O. V. Kotova, V. L. Klimov, D. I. Lebedeva
  FOCUS. Endocrinology.2023; 4(4): 12.     CrossRef
• Impaired Cardiovagal Activity as a Link Between Hyperglycemia and Arterial Stiffness in Adults With Type 2 Diabetes Mellitus Patients Among an Eastern Indian Population: A Cross-sectional Study
  Nibedita Priyadarsini, Devineni Likhitha, Madumathy Ramachandran, Kishore Kumar Behera
  Canadian Journal of Diabetes.2023;[Epub]     CrossRef
• Carvedilol improves heart rate variability indices, biomarkers but not cardiac nerve density in streptozotocin-induced T2DM model of diabetic cardiac autonomic neuropathy
  Olawale Mathias Akinlade, Bamidele Owoyele, Olufemi Ayodele Soladoye
  Journal of Basic and Clinical Physiology and Pharmacology.2022; 33(2): 213.     CrossRef
• Cardiovascular autonomic responses during head-up tilt test in newly diagnosed type 2 diabetes
  Esteban Jorge-Galarza, Margarita Torres-Tamayo, María del Rocío Martínez-Alvarado, Berenice Peña-Aparicio, Carmen González-Salazar, Juan Reyes-Barrera, Manuel Sierra-Beltrán, Erika Fajardo-Flores, Andrey Kostin, J. Antonio González-Hermosillo
  Irish Journal of Medical Science (1971 -).2022; 191(5): 2077.     CrossRef
• Cardiovascular autonomic neuropathy and incident diabetic kidney disease in patients with type 2 diabetes
  Ji Eun Jun, Min Sun Choi, Jae Hyeon Kim
  Diabetes Research and Clinical Practice.2022; 184: 109181.     CrossRef
• Kardiovaskuläre Risiken in der 4.–6. Lebensdekade mit Diabetes mellitus Typ 1
  Young Hee Lee-Barkey, Bernd Stratmann, Diethelm Tschöpe
  Der Diabetologe.2022; 18(2): 131.     CrossRef
• Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants
  Francesca Romana Prandi, Isabella Evangelista, Domenico Sergi, Alberto Palazzuoli, Francesco Romeo
  Heart Failure Reviews.2022; 28(3): 597.     CrossRef
• Comparison of Risk Assessment Strategies for Patients with Diabetes Mellitus and Stable Chest Pain: A Coronary Computed Tomography Angiography Study
  Jia Zhao, Shuo Wang, Pengyu Zhao, Yong Huo, Chunjie Li, Jia Zhou, Pawel Kleczynski
  Journal of Diabetes Research.2022; 2022: 1.     CrossRef
• BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy
  Gidon J Bönhof, Gundega Sipola, Alexander Strom, Christian Herder, Klaus Strassburger, Birgit Knebel, Claudia Reule, Jan-Christoph Wollmann, Andrea Icks, Hadi Al-Hasani, Michael Roden, Oliver Kuss, Dan Ziegler
  BMJ Open.2022; 12(2): e057142.     CrossRef
• Pragmatic Clinic-Based Investigation of Glycemic Variability in Patients With Type 1 Diabetes in Routine Clinical Practice and Its Association With Cardiovascular Autonomic Neuropathy: A Pilot Study
  Lucianne R.M. Tannus, Marilia B. Gomes
  Endocrine Practice.2022; 28(5): 465.     CrossRef
• Longitudinal effects of one‐leg standing time on neuropathy outcomes in association with glycemic control in non‐elderly patients with type 2 diabetes
  Kazuhiro Sugimoto, Takashi Sozu, Takehiko Hoshino, Yuko Watanabe, Akira Tamura, Toshiro Yamazaki, Setsu Ohta, Susumu Suzuki, Takuro Shimbo
  Journal of Diabetes Investigation.2022; 13(6): 1039.     CrossRef
• Thermal quantitative sensory testing as a screening tool for cardiac autonomic neuropathy in patients with diabetes mellitus
  Veronika Potockova, Sarka Mala, Lucie Hoskovcova, Vaclav Capek, Tomas Nedelka, Lucie Riedlbauchova, Daniel Baumgartner, Livie Mensova, Radim Mazanec
  Brain and Behavior.2022;[Epub]     CrossRef
• Cardiovascular Autonomic Reflex Tests and 7 Heart Rate Variability Indices for Early Diagnosis of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Individuals
  Yeelen Ballesteros Atala, Mozânia Reis De Matos, Denise Engelbrecht Zantut-Wittmann, Alejandro Rosell Castillo, Daniele P Santos-Bezerra, Maria Lucia Correa-Giannella, Maria Cândida Ribeiro Parisi
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Design, synthesis, in vitro and in silico studies of naproxen derivatives as dual lipoxygenase and α-glucosidase inhibitors
  Asma Sardar, Obaid-ur-Rahman Abid, Saima Daud, M. Fakhar-e-Alam, Muhammad Hussnain Siddique, Muhammad Ashraf, Wardah Shahid, Syeda Abida Ejaz, M. Atif, Shafiq Ahmad, Sulman Shafeeq, Muhammad Afzal
  Journal of Saudi Chemical Society.2022; 26(3): 101468.     CrossRef
• Clinical manifestations and evaluation of cardiac autonomic neuropathy in diabetes mellitus and metabolic syndrome
  L. S. Moshkhoeva, A. N. Barinov
  Neurology, Neuropsychiatry, Psychosomatics.2022; 14(2): 71.     CrossRef
• The relationship between vitamin B12 levels and electrocardiographic ventricular repolarization markers
  Emre Yılmaz, Devrim Kurt, Aslı Vural, Ertan Aydın, Sencer Çamcı, Ercan Aydın
  Nutrición Hospitalaria.2022;[Epub]     CrossRef
• The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double‐blinded, placebo‐controlled trial
  Suvanjaa Sivalingam, Emilie Hein Zobel, Christian S. Hansen, Rasmus S. Ripa, Bernt J. von Scholten, Viktor Rotbain Curovic, Andreas Kjaer, Jacob K. Jensen, Tine W. Hansen, Peter Rossing
  Diabetes, Obesity and Metabolism.2022; 24(8): 1638.     CrossRef
• Heart Rate Variability and Chronic Kidney Disease in Patients with Type 2 Diabetes
  Wei Shi, Jing Zhang, Dan Chen, Xiaolei Chen, Wei Duan, Hongmei Zhang, Fahd Abd Algalil
  Applied Bionics and Biomechanics.2022; 2022: 1.     CrossRef
• Spectrum of cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: A North India perspective
  PrativaPriyadarshani Sethi, Basavraj Jatteppanavar, Ravi Kant, Monika Pathania, MukeshChand Bairwa
  Journal of Cardio-diabetes and metabolic disorders.2022; 2(1): 23.     CrossRef
• Cardiac Autonomic Dysfunction Is Associated With Risk of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus
  Haixia Zeng, Jianmo Liu, Zheng Chen, Peng Yu, Jianping Liu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy
  Gidon J. Bönhof, Christian Herder, Dan Ziegler
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Triglyceride glucose index is related with cardiac autonomic dysfunction in patients with metabolic syndrome
  Akif Serhat Balcıoğlu, Ekrem Aksu, Ahmet Çağrı Aykan
  Kardiologiia.2022; 62(6): 45.     CrossRef
• Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes
  Sasha Smith, Pasha Normahani, Tristan Lane, David Hohenschurz-Schmidt, Nick Oliver, Alun Huw Davies
  Life.2022; 12(7): 1074.     CrossRef
• Correlation between impaired hemodynamic response and cardiopulmonary fitness in middle-aged type 2 diabetes mellitus patients: a case–control study
  Jinjin Xie, Lianhua Yin, Jia Huang, Ying Xu, Yannan Chen, Jiawei Qin, Zhizhen Liu, Jing Tao
  European Journal of Applied Physiology.2022; 122(10): 2295.     CrossRef
• Higher frequency of cardiovascular autonomic neuropathy in youth with type 2 compared to type 1 diabetes: Role of cardiometabolic risk factors
  Benjamin J. Varley, Megan L. Gow, Yoon Hi Cho, Paul Benitez‐Aguirre, Janine Cusumano, Alison Pryke, Albert Chan, Vallimayil Velayutham, Kim C. Donaghue, Maria E. Craig
  Pediatric Diabetes.2022; 23(7): 1073.     CrossRef
• The role of protein kinase C in diabetic microvascular complications
  Deng Pan, Lin Xu, Ming Guo
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Effect of SGLT-2 inhibitors on cardiac autonomic function in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
  Dimitrios Patoulias, Alexandra Katsimardou, Nikolaos Fragakis, Christodoulos Papadopoulos, Michael Doumas
  Acta Diabetologica.2022; 60(1): 1.     CrossRef
• Association between blood glucose levels and autonomic symptoms in Peru
  Gabriel Angeles-Zurita, Margorie Narro-Fuentes, Antonio Bernabe-Ortiz
  Primary Care Diabetes.2022; 16(5): 709.     CrossRef
• Clinical scoring systems for the risk of cardiovascular autonomic neuropathy in type 1 and type 2 diabetes: A simple tool
  Marika Menduni, Cinzia D'Amato, Martina Leoni, Valentina Izzo, Mariateresa Staltari, Carla Greco, Andrea Abbatepassero, Giuseppe Seminara, Ilenia D'Ippolito, Davide Lauro, Vincenza Spallone
  Journal of the Peripheral Nervous System.2022; 27(4): 259.     CrossRef
• Vagus nerve stimulation as a novel treatment for systemic lupus erythematous: study protocol for a randomised, parallel-group, sham-controlled investigator-initiated clinical trial, the SLE-VNS study
  Amanda Hempel Zinglersen, Ida Lynghøj Drange, Katrine Aagaard Myhr, Andreas Fuchs, Mogens Pfeiffer-Jensen, Christina Brock, Søren Jacobsen
  BMJ Open.2022; 12(9): e064552.     CrossRef
• To the interpretation of frequency components of the heart rate variability
  N. V. Kuzmenko, V. A. Tsyrlin, M. G. Pliss
  Translational Medicine.2022; 9(3): 35.     CrossRef
• Protein pyrrole adducts are associated with elevated glucose indices and clinical features of diabetic diffuse neuropathies
  Xiao Chen, Zhuyi Jiang, Lianjing Zhang, Wei Liu, Xiaohu Ren, Luling Nie, Desheng Wu, Zhiwei Guo, Weimin Liu, Xifei Yang, Yan Wu, Zhen Liang, Peter Spencer, Jianjun Liu
  Journal of Diabetes.2022; 14(10): 646.     CrossRef
• Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management
  Scott Williams, Siddig Abdel Raheim, Muhammad Ilyas Khan, Umme Rubab, Prathap Kanagala, Sizheng Steven Zhao, Anne Marshall, Emily Brown, Uazman Alam
  Clinical Therapeutics.2022; 44(10): 1394.     CrossRef
• Pathophysiological and clinical aspects of the circadian rhythm of arterial stiffness in diabetes mellitus: A minireview
  Victoria A. Serhiyenko, Ludmila M. Serhiyenko, Volodymyr B. Sehin, Alexandr A. Serhiyenko
  Endocrine Regulations.2022; 56(4): 284.     CrossRef
• Heart rate-corrected QT interval prolongation is associated with decreased heart rate variability in patients with type 2 diabetes
  Seon-Ah Cha
  Medicine.2022; 101(45): e31511.     CrossRef
• Effect of the Glucagon-Like Peptide-1 Receptor Agonists on Autonomic Function in Subjects with Diabetes: A Systematic Review and Meta-Analysis
  Carla Greco, Daniele Santi, Giulia Brigante, Chiara Pacchioni, Manuela Simoni
  Diabetes & Metabolism Journal.2022; 46(6): 901.     CrossRef
• Diabetes-Induced Cardiac Autonomic Neuropathy: Impact on Heart Function and Prognosis
  Susumu Z. Sudo, Tadeu L. Montagnoli, Bruna de S. Rocha, Aimeé D. Santos, Mauro P. L. de Sá, Gisele Zapata-Sudo
  Biomedicines.2022; 10(12): 3258.     CrossRef
• The Relationship Between Orthostatic Hypotension and Vitamin D Deficiency in Patients with Uncontrolled Type 2 Diabetes Mellitus
  Ece YİĞİT, Ridvan SİVRİTEPE, Dilay KARABULUT, Umut KARABULUT
  Online Türk Sağlık Bilimleri Dergisi.2022; 7(2): 313.     CrossRef
• A study of heart rate variability in diabetic mellitus patients
  Srinivasa Jayachandra, Satyanath Reddy Kodidala
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(3): 153.     CrossRef
• The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review
  Aikaterini Eleftheriadou, Scott Williams, Sarah Nevitt, Emily Brown, Rebecca Roylance, John P. H. Wilding, Daniel J. Cuthbertson, Uazman Alam
  Diabetologia.2021; 64(2): 288.     CrossRef
• Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross‐sectional study
  Ernesto Maddaloni, Chiara Moretti, Rossella Del Toro, Sara Sterpetti, Maria Vittoria Ievolella, Gabriele Arnesano, Rocky Strollo, Silvia Irina Briganti, Luca D'Onofrio, Paolo Pozzilli, Raffaella Buzzetti
  Diabetic Medicine.2021;[Epub]     CrossRef
• Effects of lunar cycle on fasting plasma glucose, heart rate and blood pressure in type 2 diabetic patients
  Sutanu Dutta Chowdhury, Subhasish Pramanik, Koena Bhattacharjee, Lakshmi Kanta Mondal
  Chronobiology International.2021; 38(2): 270.     CrossRef
• Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial
  Yaling Tang, Hetal Shah, Carlos Roberto Bueno Junior, Xiuqin Sun, Joanna Mitri, Maria Sambataro, Luisa Sambado, Hertzel C. Gerstein, Vivian Fonseca, Alessandro Doria, Rodica Pop-Busui
  Diabetes Care.2021; 44(1): 164.     CrossRef
• Decreased glomerular filtration rate and increased albuminuria for identification of cardiovascular autonomic neuropathy in subjects with and without diabetes
  Ying-Chuen Lai, Hung-Yuan Li, Yi-Dier Jiang, Tien-Jyun Chang, Lee-Ming Chuang
  Autonomic Neuroscience.2021; 230: 102757.     CrossRef
• Exposures influencing the developing central autonomic nervous system
  Sarah D. Schlatterer, Adre J. du Plessis
  Birth Defects Research.2021; 113(11): 845.     CrossRef
• Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial
  Triantafyllos Didangelos, Eleni Karlafti, Evangelia Kotzakioulafi, Eleni Margariti, Parthena Giannoulaki, Georgios Batanis, Solomon Tesfaye, Kοnstantinos Kantartzis
  Nutrients.2021; 13(2): 395.     CrossRef
• The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes
  Min Young Kim, Gyuri Kim, Ji Yun Park, Min Sun Choi, Ji Eun Jun, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
  Diabetes Technology & Therapeutics.2021; 23(6): 434.     CrossRef
• Insulin resistance is independently associated with cardiovascular autonomic neuropathy in type 2 diabetes
  Yingshan Liu, Yu Peng, Jing Jin, Yanshan Chen, Chuna Chen, Zhenguo Chen, Haishan Huang, Lingling Xu
  Journal of Diabetes Investigation.2021; 12(9): 1651.     CrossRef
• SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement
  Vincenza Spallone, Paul Valensi
  Diabetes & Metabolism.2021; 47(4): 101224.     CrossRef
• Reduction of Pressure Pain Sensitivity as Novel Non-pharmacological Therapeutic Approach to Type 2 Diabetes: A Randomized Trial
  Jens Faber, Ebbe Eldrup, Christian Selmer, Caroline Pichat, Sofie Korsgaard Hecquet, Torquil Watt, Svend Kreiner, Benny Karpatschof, Finn Gyntelberg, Søren Ballegaard, Albert Gjedde
  Frontiers in Neuroscience.2021;[Epub]     CrossRef
• Relationship between cardiac autonomic neuropathy and cardio-metabolic risk profile in adults with type 1 diabetes
  M. Serdarova, R. Dimova, N. Chakarova, G. Grozeva, A. Todorova, T. Tankova
  Diabetes Research and Clinical Practice.2021; 174: 108721.     CrossRef
• Differences and Similarities in Neuropathy in Type 1 and 2 Diabetes: A Systematic Review
  Mar Sempere-Bigorra, Iván Julián-Rochina, Omar Cauli
  Journal of Personalized Medicine.2021; 11(3): 230.     CrossRef
• Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives
  Ditte S. Kornum, Astrid J. Terkelsen, Davide Bertoli, Mette W. Klinge, Katrine L. Høyer, Huda H. A. Kufaishi, Per Borghammer, Asbjørn M. Drewes, Christina Brock, Klaus Krogh
  Journal of Clinical Medicine.2021; 10(7): 1392.     CrossRef
• Diabetic heart disease: A clinical update
  Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, Beverly Xin Yi Yeap, Joseph M Pappachan
  World Journal of Diabetes.2021; 12(4): 383.     CrossRef
• Novel and Emerging Electrophysiological Biomarkers of Diabetic Neuropathy and Painful Diabetic Neuropathy
  Anne Marshall, Uazman Alam, Andreas Themistocleous, Nigel Calcutt, Andrew Marshall
  Clinical Therapeutics.2021; 43(9): 1441.     CrossRef
• Cardiac Autonomic Neuropathy Is Not Reversed by Euglycemia Following Islet Transplantation
  Tejas Deshmukh, Peter Emerson, Patricia Anderson, Eddy Kizana, Philip J. O’Connell, D. Jane Holmes-Walker, James J.H. Chong
  Transplantation.2021; 105(5): 1125.     CrossRef
• Attenuation of Muscle Mass and Density Is Associated With Poor Outcomes Among Patients Undergoing Major Gynecologic Surgery: A Retrospective Cohort Study
  Lu Che, Yan Zhang, Jiawen Yu, Li Xu, Yuguang Huang
  Anesthesia & Analgesia.2021; 132(6): 1692.     CrossRef
• Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy
  Min Sun Choi, Ji Eun Jun, Sung Woon Park, Jee Hee Yoo, Jiyeon Ahn, Gyuri Kim, Sang-Man Jin, Kyu Yeon Hur, Moon-Kyu Lee, Jae Hyeon Kim
  Diabetes & Metabolism Journal.2021; 45(3): 349.     CrossRef
• Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
  Gordon Sloan, Dinesh Selvarajah, Solomon Tesfaye
  Nature Reviews Endocrinology.2021; 17(7): 400.     CrossRef
• Heart Rate Variability as a Potential Non-invasive Marker of Blood Glucose Level
  L. R. Jarman, J. L. Elliott, T. Lees, R. Clifton-Bligh, A. M. Simpson, N. Nassif, S. Lal
  Human Physiology.2021; 47(2): 209.     CrossRef
• Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications
  Alice Duque, Mauro Felippe Felix Mediano, Andrea De Lorenzo, Luiz Fernando Rodrigues Jr
  World Journal of Diabetes.2021; 12(6): 855.     CrossRef
• Gaussian process-based kernel as a diagnostic model for prediction of type 2 diabetes mellitus risk using non-linear heart rate variability features
  R. Shashikant, Uttam Chaskar, Leena Phadke, Chetankumar Patil
  Biomedical Engineering Letters.2021; 11(3): 273.     CrossRef
• Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis
  Vincenzo Maria Monda, Francesca Porcellati, Felice Strollo, Alessandro Fucili, Marcello Monesi, Ersilia Satta, Sandro Gentile
  Advances in Therapy.2021; 38(8): 4195.     CrossRef
• Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus
  Amanda Hempel Zinglersen, Katrine Kjær Iversen, Henrik Christian Bidstrup Leffers, Esben Laugesen, Jesper Fleischer, Søren Jacobsen
  Lupus Science & Medicine.2021; 8(1): e000507.     CrossRef
• Impaired vagal adaptation to an exercise task in women with gestational diabetes mellitus versus women with uncomplicated pregnancies
  Marieta P. Theodorakopoulou, Areti Triantafyllou, Andreas Zafeiridis, Afroditi Κ. Boutou, Iris Grigoriadou, Evangelia Kintiraki, Stella Douma, Dimitrios G. Goulis, Konstantina Dipla
  Hormones.2021; 20(4): 753.     CrossRef
• Cardioprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors Regardless of Type 2 Diabetes Mellitus: A Meta-analysis
  Lucas Silva Sousa, Felipe de Araújo Nascimento, Juliano Rocha, Michelle Rocha-Parise
  International Journal of Cardiovascular Sciences.2021;[Epub]     CrossRef
• Management of diabetic neuropathy
  Simona Cernea, Itamar Raz
  Metabolism.2021; 123: 154867.     CrossRef
• Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes: A systematic review
  Vinni Faber Rasmussen, Troels Staehelin Jensen, Hatice Tankisi, Páll Karlsson, Esben Thyssen Vestergaard, Kurt Kristensen, Jens Randel Nyengaard, Astrid Juhl Terkelsen
  Journal of Diabetes and its Complications.2021; 35(11): 108027.     CrossRef
• Cardiovascular Risk Management in Type 1 Diabetes
  I. H. Teoh, P. Elisaus, J. D. Schofield
  Current Diabetes Reports.2021;[Epub]     CrossRef
• Disturbances in the intraventricular conduction system in teenagers with type 1 diabetes. A pilot study
  Agnieszka Zubkiewicz-Kucharska, Anna Noczyńska, Małgorzata Sobieszczańska, Małgorzata Poręba, Joanna Chrzanowska, Rafał Poręba, Monika Seifert, Anna Janocha, Krystyna Laszki-Szcząchor
  Journal of Diabetes and its Complications.2021; 35(11): 108043.     CrossRef
• Peripheral and Autonomic Neuropathy Status of Young Patients With Type 1 Diabetes Mellitus at the Time of Transition From Pediatric Care to Adult-Oriented Diabetes Care
  Anna Vágvölgyi, Ágnes Maróti, Mónika Szűcs, Csongor Póczik, Dóra Urbán-Pap, István Baczkó, Attila Nemes, Éva Csajbók, Krisztián Sepp, Péter Kempler, Andrea Orosz, Tamás Várkonyi, Csaba Lengyel
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Pancreatic exocrine insufficiency in diabetes is associated with autonomic dysfunction
  Dag André Sangnes, Elisabeth Sandvik Bergmann, Rose Marie Moss, Trond Engjom, Eirik Søfteland
  Scandinavian Journal of Gastroenterology.2021; 56(10): 1222.     CrossRef
• Dependence of Heart Rate Variability Indices on the Mean Heart Rate in Women with Well-Controlled Type 2 Diabetes
  Adriana Robles-Cabrera, José M. Torres-Arellano, Ruben Fossion, Claudia Lerma
  Journal of Clinical Medicine.2021; 10(19): 4386.     CrossRef
• Normative data on cardiovascular autonomic function in Greenlandic Inuit
  Marie Mathilde Bjerg Christensen, Christian Stevns Hansen, Jesper Fleischer, Dorte Vistisen, Stine Byberg, Trine Larsen, Jens Christian Laursen, Marit Eika Jørgensen
  BMJ Open Diabetes Research & Care.2021; 9(1): e002121.     CrossRef
• What Is in the Field for Genetics and Epigenetics of Diabetic Neuropathy: The Role of MicroRNAs
  V. Spallone, C. Ciccacci, A. Latini, P. Borgiani, Karim Gariani
  Journal of Diabetes Research.2021; 2021: 1.     CrossRef
• Evaluation and treatment of peripheral nervous system dysfunction in patients with prediabetes
  O. E. Zinovyeva, T. M. Ostroumova, M. V. Koniashova, N. A. Gorbachev
  Neurology, Neuropsychiatry, Psychosomatics.2021; 13(5): 116.     CrossRef
• Manifestazioni cliniche della neuropatia autonomica diabetica: valutazione dei sintomi
  Carla Greco, Chiara Pacchioni, Manuela Simoni
  L'Endocrinologo.2021; 22(6): 514.     CrossRef
• Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review
  Xiaochun Zhang, Xue Yang, Bao Sun, Chunsheng Zhu
  Communications Biology.2021;[Epub]     CrossRef
• The Association Between Cardiovascular Autonomic Function and Changes in Kidney and Myocardial Function in Type 2 Diabetes and Healthy Controls
  Jens Christian Laursen, Ida Kirstine B. Rasmussen, Emilie H. Zobel, Philip Hasbak, Bernt Johan von Scholten, Lene Holmvang, Rasmus S. Ripa, Christian S. Hansen, Marie Frimodt-Moeller, Andreas Kjaer, Peter Rossing, Tine W. Hansen
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Dependence of heart rate variability on indicators of type 1 diabetes mellitus control.
  N. O. Pertseva, O. V. Gurzhiy, K. I. Moshenets
  Medicni perspektivi (Medical perspectives).2020; 25(1): 88.     CrossRef
• Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study)
  Gyuri Kim, Soo Lim, Hyuk‐Sang Kwon, Ie B. Park, Kyu J. Ahn, Cheol‐Young Park, Su K. Kwon, Hye S. Kim, Seok W. Park, Sin G. Kim, Min K. Moon, Eun S. Kim, Choon H. Chung, Kang S. Park, Mikyung Kim, Dong J. Chung, Chang B. Lee, Tae H. Kim, Moon‐Kyu Lee
  Diabetes, Obesity and Metabolism.2020; 22(9): 1527.     CrossRef
• Diabetes mellitus and comorbidities: A bad romance
  Niki Katsiki, Dimitrios Tousoulis
  Hellenic Journal of Cardiology.2020; 61(1): 23.     CrossRef
• Features of the glucose influence on the heart activity and the changes in the potentials of the stomach and the intestines at the heart insufficiency conditions
  V. V. Soltanov, L. M. Komarovskaya
  Doklady of the National Academy of Sciences of Belarus.2020; 63(6): 736.     CrossRef
• Living Day to Day
  Gerald Kayingo, Virginia McCoy Hass
  Physician Assistant Clinics.2020; 5(2): 213.     CrossRef
• Source specific PM2.5 associated with heart rate variability in the elderly with coronary heart disease: A community-based panel study
  Xi Chen, Bing Qiu, Qinpei Zou, Tian Qiu, Runkui Li, Ashley Truong, Yanmin Qi, Tao Liu, Limin Han, Tiebing Liu, Junrui Chang, Qi Sun, Ying Zhu, Dongqun Xu
  Chemosphere.2020; 260: 127399.     CrossRef
• The Association of Autonomic Nervous System Function With Ischemic Stroke, and Treatment Strategies
  Mengxi Zhao, Ling Guan, Yilong Wang
  Frontiers in Neurology.2020;[Epub]     CrossRef
• Cardiac diabetic autonomic neuropathy
  L. T. Akhmedzhanova, T. A. Belyakova, Yu. A. Podkovko, Yu. M. Shor
  Medical Council.2020; (21): 94.     CrossRef
• Diabetes, and its treatment, as an effector of autonomic nervous system circuits and its functions
  Liliana Espinoza, Carie R Boychuk
  Current Opinion in Pharmacology.2020; 54: 18.     CrossRef
• Morning blood pressure surge is associated with autonomic neuropathy and peripheral vascular disease in patients with diabetes
  Federica Di Gennaro, Cinzia D’Amato, Roberto Morganti, Carla Greco, Susanna Longo, Diana Corradini, Davide Lauro, Vincenza Spallone
  Journal of Human Hypertension.2020; 34(7): 495.     CrossRef
• The Compound Expression of HSP90 and INOS in the Testis of Diabetic Rats as Cellular and Pathologic Adverse Effects of Diabetes
  Ali Alsarhan, Kawther Faisal Amawi, Inas Saleh Al-Mazari, Hashem Abu Hurirah, Ahed J. Alkhatib
  Analytical Cellular Pathology.2020; 2020: 1.     CrossRef
• Heart rate variability features from nonlinear cardiac dynamics in identification of diabetes using artificial neural network and support vector machine
  Yogender Aggarwal, Joyani Das, Papiya Mitra Mazumder, Rohit Kumar, Rakesh Kumar Sinha
  Biocybernetics and Biomedical Engineering.2020; 40(3): 1002.     CrossRef
• Distal Symmetric and Cardiovascular Autonomic Neuropathies in Brazilian Individuals with Type 2 Diabetes Followed in a Primary Health Care Unit: A Cross-Sectional Study
  Mozania Reis de Matos, Daniele Pereira Santos-Bezerra, Cristiane das Graças Dias Cavalcante, Jacira Xavier de Carvalho, Juliana Leite, Jose Antonio Januario Neves, Sharon Nina Admoni, Marisa Passarelli, Maria Candida Parisi, Maria Lucia Correa-Giannella
  International Journal of Environmental Research and Public Health.2020; 17(9): 3232.     CrossRef
• Awareness of hypoglycemia and spectral analysis of heart rate variability in type 1 diabetes
  Ticiana Paes, L. Clemente Rolim, Celso Sallum Filho, João Roberto de Sa, Sérgio A. Dib
  Journal of Diabetes and its Complications.2020; 34(8): 107617.     CrossRef
• Is there cardiac autonomic neuropathy in prediabetes?
  Lindsay A. Zilliox, James W. Russell
  Autonomic Neuroscience.2020; 229: 102722.     CrossRef
• Chronic Microvascular Complications in Prediabetic States—An Overview
  Angelika Baranowska-Jurkun, Wojciech Matuszewski, Elżbieta Bandurska-Stankiewicz
  Journal of Clinical Medicine.2020; 9(10): 3289.     CrossRef
• Cardiac vagal tone as a novel screening tool to recognize asymptomatic cardiovascular autonomic neuropathy: Aspects of utility in type 1 diabetes
  Anne-Marie Wegeberg, Elin D Lunde, Sam Riahi, Niels Ejskjaer, Asbjørn M Drewes, Birgitte Brock, Rodica Pop-Busui, Christina Brock
  Diabetes Research and Clinical Practice.2020; 170: 108517.     CrossRef
• Assessment of baroreceptor reflex sensitivity in young obese Saudi males at rest and in response to physiological challenges
  Abdullah N. AlShahrani, Lubna I. Al‐Asoom, Ahmed A. Alsunni, Nabil S. Elbahai, Talay Yar
  Physiological Reports.2020;[Epub]     CrossRef
• The relationship between QT interval indices with cardiac autonomic neuropathy in diabetic patients: a case control study
  Maryam Vasheghani, Farzaneh Sarvghadi, Mohammad Reza Beyranvand, Habib Emami
  Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
• Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options
  Péter Bencsik, Kamilla Gömöri, Tamara Szabados, Péter Sántha, Zsuzsanna Helyes, Gábor Jancsó, Péter Ferdinandy, Anikó Görbe
  British Journal of Pharmacology.2020; 177(23): 5336.     CrossRef
• Biological Activity of c-Peptide in Microvascular Complications of Type 1 Diabetes—Time for Translational Studies or Back to the Basics?
  Aleksandra Ryk, Aleksandra Łosiewicz, Arkadiusz Michalak, Wojciech Fendler
  International Journal of Molecular Sciences.2020; 21(24): 9723.     CrossRef
• Diabetes and cardiovascular disease: inter-relation of risk factors and treatment
  Aman Sharma, Shweta Mittal, Rohan Aggarwal, Meenakshi K. Chauhan
  Future Journal of Pharmaceutical Sciences.2020;[Epub]     CrossRef
• Diabetic Autonomic Neuropathy: A Clinical Update
  Jugal Kishor Sharma, Anshu Rohatgi, Dinesh Sharma
  Journal of the Royal College of Physicians of Edinburgh.2020; 50(3): 269.     CrossRef
• Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus
  Niki Katsiki, Panagiotis Anagnostis, Kalliopi Kotsa, Dimitrios G. Goulis, Dimitri P. Mikhailidis
  Current Pharmaceutical Design.2019; 25(18): 2051.     CrossRef
• Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review
  Scott M. Williams, Aikaterini Eleftheriadou, Uazman Alam, Daniel J. Cuthbertson, John P. H. Wilding
  Diabetes Therapy.2019; 10(6): 1995.     CrossRef

The glucagon-like peptide-1 receptor agonists (GLP-1RAs) were recommended as a monotherapy or combination therapy with oral hypoglycemic agents or basal insulin in the position statement of the Korean Diabetes Association 2017 for pharmacological therapy. Many randomized clinical trials and systematic reviews report that GLP-1RAs have considerable glucose-lowering effect and lead to weight reduction and low risk of hypoglycemia when used as a monotherapy or combination therapy. The cardiovascular safety of GLP-1RAs has been assessed in several randomized clinical trials and systematic reviews. The results of cardiovascular outcome trials of long-acting GLP-1RAs (liraglutide, semaglutide) demonstrated cardiovascular benefits in subjects with type 2 diabetes mellitus and a high risk of cardiovascular disease. The GLP-1RA may be a choice of therapy when weight control and avoidance of hypoglycemia are important, and patients with high risk of cardiovascular disease might also favor choosing GLP-1RA.

Citations

Citations to this article as recorded by  

• Anti-inflammatory effect of glucagon-like Peptide-1 receptor agonist on the neurosensory retina in an acute optic nerve injury rat model
  Yeon Woong Chung, Ji Young Lee, Hyun Hee Ju, Jin A. Choi
  European Journal of Pharmacology.2022; 933: 175269.     CrossRef
• Diabetes Risk Data Mining Method Based on Electronic Medical Record Analysis
  Yang Liu, Zhaoxiang Yu, Yunlong Yang, Zhihan Lv
  Journal of Healthcare Engineering.2021; 2021: 1.     CrossRef
• Paradigm Shift for the Treatment of Type 2 Diabetes Mellitus in Patients with Cardiovascular Disease: Cardiologist's Perspective
  Doo Soo Jeon
  Cardiovascular Prevention and Pharmacotherapy.2020; 2(1): 11.     CrossRef
• The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
  Ju-Ming Lu
  Advances in Therapy.2019; 36(4): 798.     CrossRef
• A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes
  Irene Romera, Ana Cebrián-Cuenca, Fernando Álvarez-Guisasola, Fernando Gomez-Peralta, Jesús Reviriego
  Diabetes Therapy.2019; 10(1): 5.     CrossRef
• Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
  Hyun Jin Kim
  The Journal of Korean Diabetes.2018; 19(1): 35.     CrossRef

Type 2 diabetes mellitus (T2DM) is a multifactorial disease with a complex and progressive pathogenesis. The two primary mechanisms of T2DM pathogenesis are pancreatic β-cell dysfunction and insulin resistance. Pancreatic β-cell dysfunction is recognized to be a prerequisite for the development of T2DM. Therapeutic modalities that improve β-cell function are considered critical to T2DM management; however, blood glucose control remains a challenge for many patients due to suboptimal treatment efficacy and the progressive nature of T2DM. Incretin-based therapies are now the most frequently prescribed antidiabetic drugs in Korea. Incretin-based therapies are a favorable class of drugs due to their ability to reduce blood glucose by targeting the incretin hormone system and, most notably, their potential to improve pancreatic β-cell function. This review outlines the current understanding of the incretin hormone system in T2DM and summarizes recent updates on the effect of incretin-based therapies on β-cell function and β-cell mass in animals and humans.

Citations

Citations to this article as recorded by  

• Harnessing gut cells for functional insulin production: Strategies and challenges
  Kelvin Baafi, John C. March
  Biotechnology Notes.2023; 4: 7.     CrossRef
• Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
  Chang Ho Ahn, Tae Jung Oh, Se Hee Min, Young Min Cho
  Endocrinology and Metabolism.2023; 38(1): 1.     CrossRef
• Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response, and beta cell function
  Simon B. K. Jensen, Christian R. Juhl, Charlotte Janus, Julie R. Lundgren, Christoffer Martinussen, Christoffer Wiingaard, Cecilie Knudsen, Ruth Frikke‐Schmidt, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad, Signe S. Torekov
  Obesity.2023; 31(4): 977.     CrossRef
• How do parasitic worms prevent diabetes? An exploration of their influence on macrophage and β-cell crosstalk
  Inah Camaya, Bronwyn O’Brien, Sheila Donnelly
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• An Imbalance of Pathophysiologic Factors in Late Postprandial Hypoglycemia Post Bariatric Surgery: A Narrative Review
  Marah Alsayed Hasan, Stanley Schwartz, Victoria McKenna, Richard Ing
  Obesity Surgery.2023; 33(9): 2927.     CrossRef
• Therapeutic Dilemma in Personalized Medicine
  Ehab S. EL Desoky
  Current Reviews in Clinical and Experimental Pharmacology.2022; 17(2): 94.     CrossRef
• Lessons from neonatal β-cell epigenomic for diabetes prevention and treatment
  Amar Abderrahmani, Cécile Jacovetti, Romano Regazzi
  Trends in Endocrinology & Metabolism.2022; 33(6): 378.     CrossRef
• Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists
  Neil Tanday, Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
  Diabetes, Obesity and Metabolism.2022; 24(12): 2353.     CrossRef
• A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes
  Chih-Yuan Wang, Kuo-Chin Huang, Chia-Wen Lu, Chih-Hsun Chu, Chien-Ning Huang, Harn-Shen Chen, I-Te Lee, Jung-Fu Chen, Ching-Chu Chen, Chung-Sen Chen, Chang-Hsun Hsieh, Kai-Jen Tien, Hung-Yu Chien, Yu-Yao Huang, Jui-Pao Hsu, Guang-Tzuu Shane, Ai-Ching Chan
  The Journal of Clinical Endocrinology & Metabolism.2022; 107(10): e4063.     CrossRef
• Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study
  Tao Tao, Yi Zhang, Yu-Chen Zhu, Jia-Rong Fu, Yu-Ying Wang, Jie Cai, Jing-Yu Ma, Yu Xu, Yi-Ning Gao, Yun Sun, WuQiang Fan, Wei Liu
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(3): e1420.     CrossRef
• The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study
  Tuccinardi Dario, Giorgino Riccardo, Pieralice Silvia, Watanabe Mikiko, Maggi Daria, Palermo Andrea, Defeudis Giuseppe, Fioriti Elvira, Pozzilli Paolo, Manfrini Silvia
  Acta Diabetologica.2021; 58(4): 411.     CrossRef
• Type 2 diabetes: evidence-based medicine approach to glucose-lowering therapy
  E. V. Biryukova, I. A. Morozova, S. V. Rodionova
  Meditsinskiy sovet = Medical Council.2021; (21): 160.     CrossRef
• Emerging Role of Caveolin-1 in GLP-1 Action
  Alessandra Puddu, Davide Maggi
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Improvements in HOMA indices and pancreatic endocrinal tissues in type 2-diabetic rats by DPP-4 inhibition and antioxidant potential of an ethanol fruit extract of Withania coagulans
  Heera Ram, Pramod Kumar, Ashok Purohit, Priya Kashyap, Suresh Kumar, Shivani Kumar, Garima Singh, Abdulaziz A. Alqarawi, Abeer Hashem, Elsayed Fathi Abd-Allah, Al-Bandari Fahad Al-Arjani, Bhim Pratap Singh
  Nutrition & Metabolism.2021;[Epub]     CrossRef
• Chop / Ddit3 depletion in β cells alleviates ER stress and corrects hepatic steatosis in mice
  Jing Yong, Vishal S. Parekh, Shannon M. Reilly, Jonamani Nayak, Zhouji Chen, Cynthia Lebeaupin, Insook Jang, Jiangwei Zhang, Thazha P. Prakash, Hong Sun, Sue Murray, Shuling Guo, Julio E. Ayala, Leslie S. Satin, Alan R. Saltiel, Randal J. Kaufman
  Science Translational Medicine.2021;[Epub]     CrossRef
• Assessment of Insulin Secretion and Insulin Resistance in Human
  So Young Park, Jean-François Gautier, Suk Chon
  Diabetes & Metabolism Journal.2021; 45(5): 641.     CrossRef
• Targeted pharmacological therapy restores β-cell function for diabetes remission
  Stephan Sachs, Aimée Bastidas-Ponce, Sophie Tritschler, Mostafa Bakhti, Anika Böttcher, Miguel A. Sánchez-Garrido, Marta Tarquis-Medina, Maximilian Kleinert, Katrin Fischer, Sigrid Jall, Alexandra Harger, Erik Bader, Sara Roscioni, Siegfried Ussar, Annett
  Nature Metabolism.2020; 2(2): 192.     CrossRef
• The Relationship Between Timing of Initiation on a Glucagon-like Peptide-1 Receptor Agonist and Glycosylated Hemoglobin Values Among Patients With Type 2 Diabetes
  Kristina S. Boye, Reema Mody, Maureen J. Lage, Raleigh E. Malik
  Clinical Therapeutics.2020; 42(9): 1812.     CrossRef
• Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study
  Valentina K. Bayrasheva, Ivan Y. Pchelin, Vladimir A. Dobronravov, Alina Yu. Babenko, Svetlana G. Chefu, Ivan S. Shatalov, Volha N. Vasilkova, Natalia V. Hudiakova, Alexandra N. Ivanova, Pavel A. Andoskin, Elena N. Grineva
  Archives of Endocrinology and Metabolism.2020;[Epub]     CrossRef
• A Phenotypic Screen Identifies Calcium Overload as a Key Mechanism of β-Cell Glucolipotoxicity
  Jennifer Vogel, Jianning Yin, Liansheng Su, Sharon X. Wang, Richard Zessis, Sena Fowler, Chun-Hao Chiu, Aaron C. Wilson, Amy Chen, Frederic Zecri, Gordon Turner, Thomas M. Smith, Brian DeChristopher, Heming Xing, Deborah M. Rothman, Xinming Cai, Alina Ber
  Diabetes.2020; 69(5): 1032.     CrossRef
• Neuropeptide 26RFa (QRFP) is a key regulator of glucose homeostasis and its activity is markedly altered in obese/hyperglycemic mice
  Gaëtan Prévost, Arnaud Arabo, Marie-Anne Le Solliec, Justine Bons, Marie Picot, Julie Maucotel, Hind Berrahmoune, Mouna El Mehdi, Saloua Cherifi, Alexandre Benani, Emmanuelle Nédélec, Moïse Coëffier, Jérôme Leprince, Anneli Nordqvist, Valéry Brunel, Pierr
  American Journal of Physiology-Endocrinology and Metabolism.2019; 317(1): E147.     CrossRef
• Gastrin analogue administration adds no significant glycaemic benefit to a glucagon‐like peptide‐1 receptor agonist acutely or after washout of both analogues
  Krister Bokvist, Ying Ding, William H. Landschulz, Vikram Sinha, Aleksandra Pastrak, Ruth M. Belin
  Diabetes, Obesity and Metabolism.2019; 21(7): 1606.     CrossRef
• Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1
  Lie-Chwen Lin, Lin-Chien Lee, Cheng Huang, Chiung-Tong Chen, Jen-Shin Song, Young-Ji Shiao, Hui-Kang Liu
  Phytomedicine.2019; 62: 152946.     CrossRef
• The future of new drugs for diabetes management
  Clifford J. Bailey, Caroline Day
  Diabetes Research and Clinical Practice.2019; 155: 107785.     CrossRef
• Compact fluidic system for functional assessment of pancreatic islets
  Takeshi Hori, Kei Yamane, Takayuki Anazawa, Osamu Kurosawa, Hiroo Iwata
  Biomedical Microdevices.2019;[Epub]     CrossRef
• Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and Bydureon
  Yazhou Li, Kelli L. Vaughan, David Tweedie, Jin Jung, Hee Kyung Kim, Ho-Il Choi, Dong Seok Kim, Julie A. Mattison, Nigel H. Greig
  Scientific Reports.2019;[Epub]     CrossRef
• Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury
  Miaad Bader, Yazhou Li, Daniela Lecca, Vardit Rubovitch, David Tweedie, Elliot Glotfelty, Lital Rachmany, Hee Kyung Kim, Ho-Il Choi, Barry J. Hoffer, Chaim G. Pick, Nigel H. Greig, Dong Seok Kim
  Neurobiology of Disease.2019; 124: 439.     CrossRef
• Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential
  N.M. Pathak, V. Pathak, V.A. Gault, S. McClean, N. Irwin, P.R. Flatt
  Biochemical Pharmacology.2018; 155: 264.     CrossRef
• Human EndoC-βH1 β-cells form pseudoislets with improved glucose sensitivity and enhanced GLP-1 signaling in the presence of islet-derived endothelial cells
  Michael G. Spelios, Lauren A. Afinowicz, Regine C. Tipon, Eitan M. Akirav
  American Journal of Physiology-Endocrinology and Metabolism.2018; 314(5): E512.     CrossRef
• Vildagliptin: ten years in the service for type 2 diabetes mellitus patients. The journey of discovery, innovation and success in clinical practice
  Tatiana Yu. Demidova
  Problems of Endocrinology.2018; 64(5): 336.     CrossRef
• Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss
  Paola Simeone, Rossella Liani, Romina Tripaldi, Augusto Di Castelnuovo, Maria Guagnano, Armando Tartaro, Riccardo Bonadonna, Virginia Federico, Francesco Cipollone, Agostino Consoli, Francesca Santilli
  Nutrients.2018; 10(12): 1872.     CrossRef
• Nutrient regulation of β-cell function: what do islet cell/animal studies tell us?
  R Carlessi, K N Keane, C Mamotte, P Newsholme
  European Journal of Clinical Nutrition.2017; 71(7): 890.     CrossRef
• Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice
  You-Cheol Hwang, Ari Kim, Euna Jo, Yeoree Yang, Jae-Hyoung Cho, Byung-Wan Lee
  BMC Endocrine Disorders.2017;[Epub]     CrossRef
• Efficacy and safety of adding evogliptin versus sitagliptin for metformin‐treated patients with type 2 diabetes: A 24‐week randomized, controlled trial with open label extension
  Sang‐Mo Hong, Cheol‐Young Park, Dong‐Min Hwang, Kyung Ah Han, Chang Beom Lee, Choon Hee Chung, Kun‐Ho Yoon, Ji‐Oh Mok, Kyong Soo Park, Sung‐Woo Park
  Diabetes, Obesity and Metabolism.2017; 19(5): 654.     CrossRef
• The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)
  Naoyuki Kitao, Hideaki Miyoshi, Tomoo Furumoto, Kota Ono, Hiroshi Nomoto, Aika Miya, Chiho Yamamoto, Atsushi Inoue, Kenichi Tsuchida, Naoki Manda, Yoshio Kurihara, Shin Aoki, Akinobu Nakamura, Tatsuya Atsumi
  Cardiovascular Diabetology.2017;[Epub]     CrossRef
• Recent Advances in Effect‐directed Enzyme Assays based on Thin‐layer Chromatography
  Sarah Bräm, Evelyn Wolfram
  Phytochemical Analysis.2017; 28(2): 74.     CrossRef
• Efficacy and safety of gemigliptin, a dipeptidyl peptidase‐4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24‐week, multicentre, randomized, double‐blind, placebo‐
  Chang Ho Ahn, Kyung Ah Han, Jae Myung Yu, Joo Young Nam, Kyu Jeung Ahn, Tae Keun Oh, Hyoung Woo Lee, Dae Ho Lee, Jaetaek Kim, Choon Hee Chung, Tae Sun Park, Byung Joon Kim, Seok Won Park, Hyeong Kyu Park, Kwang Jae Lee, Sang‐Wook Kim, Jeong Hyun Park, Kwa
  Diabetes, Obesity and Metabolism.2017; 19(5): 635.     CrossRef
• Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef
• Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef
• DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control
  Eun Ju Bae
  Archives of Pharmacal Research.2016; 39(8): 1114.     CrossRef
• Liraglutide Enhances the Efficacy of Human Mesenchymal Stem Cells in Preserving Islet ß-cell Function in Severe Non-obese Diabetic Mice
  Li-rong Li, Jing Lu, Xiao-lei Jia, Hui Hui, Jie Zhang, Ying Liu, Wei-juan Cui, Qian-yue Xu, Da-long Zhu
  Molecular Medicine.2016; 22(1): 800.     CrossRef

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce glycosylated hemoglobin (HbA1c, 0.5% to 1.0%), and are associated with moderate weight loss and a relatively low risk of hypoglycemia. There are differences between Asian and non-Asian populations. We reviewed available data on GLP-1RAs, focusing on Korean patients, to better understand their risk/benefit profile and help inform local clinical practice. Control of postprandial hyperglycemia is important in Asians in whom the prevalence of post-challenge hyperglycemia is higher (vs. non-Asians). The weight lowering effects of GLP-1RAs are becoming more salient as the prevalence of overweight and obesity among Korean patients increases. The higher rate of gastrointestinal adverse events amongst Asian patients in clinical trials may be caused by higher drug exposure due to the lower body mass index of the participants (vs. non-Asian studies). Data on the durability of weight loss, clinically important health outcomes, safety and optimal dosing in Korean patients are lacking. Use of GLP-1RAs is appropriate in several patient groups, including patients whose HbA1c is uncontrolled, especially if this is due to postprandial glucose excursions and patients who are overweight or obese due to dietary problems (e.g., appetite control). The potential for gastrointestinal adverse events should be explained to patients at treatment initiation to facilitate the promotion of better compliance.

Citations

Citations to this article as recorded by  

• Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
  Youngsook Kim, Ji Hye Huh, Minyoung Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef
• Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef

The sweet taste receptor is expressed in taste cells located in taste buds of the tongue. This receptor senses sweet substances in the oral cavity, activates taste cells, and transmits the taste signals to adjacent neurons. The sweet taste receptor is a heterodimer of two G protein-coupled receptors, T1R2 and T1R3. Recent studies have shown that this receptor is also expressed in the extragustatory system, including the gastrointestinal tract, pancreatic β-cells, and glucose-responsive neurons in the brain. In the intestine, the sweet taste receptor regulates secretion of incretin hormones and glucose uptake from the lumen. In β-cells, activation of the sweet taste receptor leads to stimulation of insulin secretion. Collectively, the sweet taste receptor plays an important role in recognition and metabolism of energy sources in the body.

Citations

Citations to this article as recorded by  

• Targeting T2Rs, a feasible approach for natural bitter agents from traditional Chinese medicine modulate ABC transporters to treat respiratory diseases
  Qi Liang, Ruo-Lan Li, Dan-Dan Tang, Ting Zhang, Lian Zhong, Chun-Jie Wu, Wei Peng
  Arabian Journal of Chemistry.2024; 17(1): 105377.     CrossRef
• Impact of dietary sucralose and sucrose-sweetened water intake on lipid and glucose metabolism in male mice
  Xinyi Wu, Le Cui, Haoquan Wang, Jinhong Xu, Zhaozhao Zhong, Xibei Jia, Jiaqi Wang, Huahua Zhang, Yanteng Shi, Yuhang Tang, Qianhui Yang, Qiongdan Liang, Yujing Zhang, Jing Li, Xiaohong Jiang
  European Journal of Nutrition.2023; 62(1): 199.     CrossRef
• How dietary amino acids and high protein diets influence insulin secretion
  Yuuki Yanagisawa
  Physiological Reports.2023;[Epub]     CrossRef
• The elusive cephalic phase insulin response: triggers, mechanisms, and functions
  Wolfgang Langhans, Alan G. Watts, Alan C. Spector
  Physiological Reviews.2023; 103(2): 1423.     CrossRef
• Trace Amine-Associated Receptors and Monoamine-Mediated Regulation of Insulin Secretion in Pancreatic Islets
  Anastasia N. Vaganova, Taisiia S. Shemyakova, Karina V. Lenskaia, Roman N. Rodionov, Charlotte Steenblock, Raul R. Gainetdinov
  Biomolecules.2023; 13(11): 1618.     CrossRef
• Gene expression analyses of TAS1R taste receptors relevant to the treatment of cardiometabolic disease
  Mariah R Stavrou, Sean Souchiart So, Angela M Finch, Sara Ballouz, Nicola J Smith
  Chemical Senses.2023;[Epub]     CrossRef
• Dysgeusia
  Davis C. Thomas, Deepti Chablani, Srishti Parekh, Reshmy Chellam Pichammal, Karpagavalli Shanmugasundaram, Priyanka Kodaganallur Pitchumani
  The Journal of the American Dental Association.2022; 153(3): 251.     CrossRef
• Oral Microbiota-Host Interaction Mediated by Taste Receptors
  Hao Dong, Jiaxin Liu, Jianhui Zhu, Zhiyan Zhou, Marco Tizzano, Xian Peng, Xuedong Zhou, Xin Xu, Xin Zheng
  Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
• New frontiers in the hunger management involving GLP‐1, taste and oestrogen
  Maja Baretić
  Diabetic Medicine.2022;[Epub]     CrossRef
• The Impact of Artificial Sweeteners on Body Weight Control and Glucose Homeostasis
  Michelle D. Pang, Gijs H. Goossens, Ellen E. Blaak
  Frontiers in Nutrition.2021;[Epub]     CrossRef
• TAS1R2 sweet taste receptor genetic variation and dietary intake in Korean females
  Jeong-Hwa Choi
  Appetite.2021; 164: 105281.     CrossRef
• Sweet Taste Is Complex: Signaling Cascades and Circuits Involved in Sweet Sensation
  Elena von Molitor, Katja Riedel, Michael Krohn, Mathias Hafner, Rüdiger Rudolf, Tiziana Cesetti
  Frontiers in Human Neuroscience.2021;[Epub]     CrossRef
• Hazardous Hyperglisemic Effect of Facial Ischemia Following Subarachnoid Hemorrhage: An Experimental Study
  Mehmet Dumlu Aydin, Ozgur Caglar, Mehmet Nuri Kocak, Erdem Karadeniz, Nazan Aydin, Irem Ates, Sevilay Ozmen
  Archives of Neuroscience.2020;[Epub]     CrossRef
• Determinants of Sweetness Preference: A Scoping Review of Human Studies
  Carolina Venditti, Kathy Musa-Veloso, Han Youl Lee, Theresa Poon, Alastair Mak, Maryse Darch, Justine Juana, Dylan Fronda, Daniel Noori, Erika Pateman, Maia Jack
  Nutrients.2020; 12(3): 718.     CrossRef
• Allelic variation of the Tas1r3 taste receptor gene affects sweet taste responsiveness and metabolism of glucose in F1 mouse hybrids
  Vladimir O. Murovets, Ekaterina A. Lukina, Egor A. Sozontov, Julia V. Andreeva, Raisa P. Khropycheva, Vasiliy A. Zolotarev, Keiko Abe
  PLOS ONE.2020; 15(7): e0235913.     CrossRef
• Effect of sucralose and aspartame on glucose metabolism and gut hormones
  Samar Y Ahmad, James K Friel, Dylan S Mackay
  Nutrition Reviews.2020; 78(9): 725.     CrossRef
• Maternal low protein exposure alters glucose tolerance and intestinal nutrient-responsive receptors and transporters expression of rat offspring
  Nan Wang, Bo Lv, Limin Guan, Hu Qiao, Bo Sun, Xiao Luo, Ru Jia, Ke Chen, Jianqun Yan
  Life Sciences.2020; 243: 117216.     CrossRef
• Sugar Reduction in Dairy Food: An Overview with Flavoured Milk as an Example
  Dipendra Kumar Mahato, Russell Keast, Djin Gie Liem, Catherine Georgina Russell, Sara Cicerale, Shirani Gamlath
  Foods.2020; 9(10): 1400.     CrossRef
• Electrophysiology of the pancreatic islet β-cell sweet taste receptor TIR3
  Juan V. Sanchez-Andres, Willy J. Malaisse, Itaru Kojima
  Pflügers Archiv - European Journal of Physiology.2019; 471(4): 647.     CrossRef
• A Single 48 mg Sucralose Sip Unbalances Monocyte Subpopulations and Stimulates Insulin Secretion in Healthy Young Adults
  Angélica Y. Gómez-Arauz, Nallely Bueno-Hernández, Leon F. Palomera, Raúl Alcántara-Suárez, Karen L. De León, Lucía A. Méndez-García, Miguel Carrero-Aguirre, Aaron N. Manjarrez-Reyna, Camilo P. Martínez-Reyes, Marcela Esquivel-Velázquez, Alejandra Ruiz-Bar
  Journal of Immunology Research.2019; 2019: 1.     CrossRef
• Sugar reduction without compromising sensory perception. An impossible dream?
  Scott C. Hutchings, Julia Y. Q. Low, Russell S. J. Keast
  Critical Reviews in Food Science and Nutrition.2019; 59(14): 2287.     CrossRef
• Oral and Post‐Oral Actions of Low‐Calorie Sweeteners: A Tale of Contradictions and Controversies
  John I. Glendinning
  Obesity.2018;[Epub]     CrossRef
• Olfactory, Taste, and Photo Sensory Receptors in Non-sensory Organs: It Just Makes Sense
  Nicholas M. Dalesio, Sebastian F. Barreto Ortiz, Jennifer L. Pluznick, Dan E. Berkowitz
  Frontiers in Physiology.2018;[Epub]     CrossRef
• Emerging Concepts in Brain Glucose Metabolic Functions: From Glucose Sensing to How the Sweet Taste of Glucose Regulates Its Own Metabolism in Astrocytes and Neurons
  Menizibeya O. Welcome, Nikos E. Mastorakis
  NeuroMolecular Medicine.2018; 20(3): 281.     CrossRef
• Anti-diabetic effects of natural products an overview of therapeutic strategies
  Jiyoung Park, Hyeung-Jin Jang
  Molecular & Cellular Toxicology.2017; 13(1): 1.     CrossRef
• Natural sweetener agave inhibits gastric emptying in rats by a cholecystokinin-2- and glucagon like peptide-1 receptor-dependent mechanism
  E. Bihter Gürler, Dilek Özbeyli, Hülya Buzcu, Sezin Bayraktar, İrem Carus, Beyza Dağ, Yasemin Geriş, Seda Jeral, Berrak Ç. Yeğen
  Food & Function.2017; 8(2): 741.     CrossRef
• T1R3 homomeric sweet taste receptor regulates adipogenesis through Gαs-mediated microtubules disassembly and Rho activation in 3T3-L1 cells
  Yosuke Masubuchi, Yuko Nakagawa, Johan Medina, Masahiro Nagasawa, Itaru Kojima, Mark M. Rasenick, Takeshi Inagaki, Hiroshi Shibata, Hiroaki Matsunami
  PLOS ONE.2017; 12(5): e0176841.     CrossRef
• Hormonal responses to non-nutritive sweeteners in water and diet soda
  Allison C. Sylvetsky, Rebecca J. Brown, Jenny E. Blau, Mary Walter, Kristina I. Rother
  Nutrition & Metabolism.2016;[Epub]     CrossRef
• Gastrointestinal defense mechanisms
  Hyder Said, Jonathan D. Kaunitz
  Current Opinion in Gastroenterology.2016; 32(6): 461.     CrossRef
• Glucose-Sensing Receptor T1R3: A New Signaling Receptor Activated by Glucose in Pancreatic β-Cells
  Itaru Kojima, Yuko Nakagawa, Kunihisa Hamano, Johan Medina, Longfei Li, Masahiro Nagasawa
  Biological & Pharmaceutical Bulletin.2015; 38(5): 674.     CrossRef
• Impaired Glucose Metabolism in Mice Lacking the Tas1r3 Taste Receptor Gene
  Vladimir O. Murovets, Alexander A. Bachmanov, Vasiliy A. Zolotarev, Hiroaki Matsunami
  PLOS ONE.2015; 10(6): e0130997.     CrossRef
• Sweet Taste Receptor Signaling Network: Possible Implication for Cognitive Functioning
  Menizibeya O. Welcome, Nikos E. Mastorakis, Vladimir A. Pereverzev
  Neurology Research International.2015; 2015: 1.     CrossRef
• Expression of the glucose-sensing receptor T1R3 in pancreatic islet: changes in the expression levels in various nutritional and metabolic states
  Anya Medina, Yuko Nakagawa, Jinhui Ma, Longfei Li, Kunihisa Hamano, Toshio Akimoto, Yuzo Ninomiya, Itaru Kojima
  Endocrine Journal.2014; 61(8): 797.     CrossRef
• Normal Roles for Dietary Fructose in Carbohydrate Metabolism
  Maren Laughlin
  Nutrients.2014; 6(8): 3117.     CrossRef
• Glucose promotes its own metabolism by acting on the cell-surface glucose-sensing receptor T1R3
  Yuko Nakagawa, Yoshiaki Ohtsu, Masahiro Nagasawa, Hiroshi Shibata, Itaru Kojima
  Endocrine Journal.2014; 61(2): 119.     CrossRef
• Diverse signaling systems activated by the sweet taste receptor in human GLP-1-secreting cells
  Yoshiaki Ohtsu, Yuko Nakagawa, Masahiro Nagasawa, Shigeki Takeda, Hirokazu Arakawa, Itaru Kojima
  Molecular and Cellular Endocrinology.2014; 394(1-2): 70.     CrossRef
• Sweet Taste-Sensing Receptors Expressed in Pancreatic β-Cells: Sweet Molecules Act as Biased Agonists
  Itaru Kojima, Yuko Nakagawa, Yoshiaki Ohtsu, Anya Medina, Masahiro Nagasawa
  Endocrinology and Metabolism.2014; 29(1): 12.     CrossRef
• The Role of Sweet Taste in Satiation and Satiety
  Yu Low, Kathleen Lacy, Russell Keast
  Nutrients.2014; 6(9): 3431.     CrossRef
• Insulin release: the receptor hypothesis
  Willy J. Malaisse
  Diabetologia.2014; 57(7): 1287.     CrossRef
• The involvement of the T1R3 receptor protein in the control of glucose metabolism in mice at different levels of glycemia
  V. O. Murovets, A. A. Bachmanov, S. V. Travnikov, A. A. Churikova, V. A. Zolotarev
  Journal of Evolutionary Biochemistry and Physiology.2014; 50(4): 334.     CrossRef
• GKAs for diabetes therapy: why no clinically useful drug after two decades of trying?
  Franz M. Matschinsky
  Trends in Pharmacological Sciences.2013; 34(2): 90.     CrossRef
• A Novel Regulatory Function of Sweet Taste-Sensing Receptor in Adipogenic Differentiation of 3T3-L1 Cells
  Yosuke Masubuchi, Yuko Nakagawa, Jinhui Ma, Tsutomu Sasaki, Tadahiro Kitamura, Yoritsuna Yamamoto, Hitoshi Kurose, Itaru Kojima, Hiroshi Shibata, Xing-Ming Shi
  PLoS ONE.2013; 8(1): e54500.     CrossRef
• Goût des aliments et comportement alimentaire
  M. Fantino
  Médecine des Maladies Métaboliques.2012; 6(5): 409.     CrossRef
• The role of T1r3 and Trpm5 in carbohydrate-induced obesity in mice
  John I. Glendinning, Jennifer Gillman, Haley Zamer, Robert F. Margolskee, Anthony Sclafani
  Physiology & Behavior.2012; 107(1): 50.     CrossRef
• Repair of diverse diabetic defects of β‐cells in man and mouse by pharmacological glucokinase activation
  Nicolai M. Doliba, Deborah Fenner, Bogumil Zelent, Joseph Bass, Ramakanth Sarabu, Franz M. Matschinsky
  Diabetes, Obesity and Metabolism.2012; 14(s3): 109.     CrossRef

Type 2 diabetes mellitus (T2DM) is increasing in prevalence worldwide. The complications associated with T2DM result in increased mortality and financial cost for those affected. T2DM has long been known to be associated with insulin resistance in peripheral tissues and a relative degree of insulin deficiency. However, the concept that insulin secretion and insulin sensitivity are not linked through a hyperbolic relationship in T2DM has continuously been demonstrated in many clinical trials. Thus, in order to prevent and treat T2DM, it is necessary to identify the substance(s) that will improve the function and survival of the pancreatic β-cells in both normal and pathologic conditions, so that production and secretion of insulin can be enhanced. Incretin hormones, such as glucagon-like peptide (GLP)-1 and glucose-dependent insulinotropic polypeptide (GIP), have been shown to lower the postprandial and fasting glucose and the glycated hemoglobin levels, suppress the elevated glucagon level, and stimulate glucose-dependent insulin synthesis and secretion. In this report, we will review the biological actions and mechanisms associated with the actions of incretin hormones, GLP-1 and GIP, on β-cell health and compare the differences between GLP-1 and GIP.

Citations

Citations to this article as recorded by  

• A phase I study comparing the pharmacokinetics of the biosimilar (RD12014) with liraglutide (Victoza) in healthy Chinese male subjects
  Ruirui Zhou, Linfeng Guo, Xianglei Gao, Yijun Wang, Wenjing Xu, Yang Zou, Wenjia Li, Yulei Zhuang, Gangyi Liu, Yanmei Liu
  Clinical and Translational Science.2022; 15(10): 2458.     CrossRef
• Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases
  Mustafa Karabicici, Yagmur Azbazdar, Evin Iscan, Gunes Ozhan
  Membranes.2021; 11(11): 844.     CrossRef
• Effects of newly introduced antidiabetic drugs on autophagy
  Milad Ashrafizadeh, Habib Yaribeygi, Stephen L. Atkin, Amirhossein Sahebkar
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(4): 2445.     CrossRef
• Genistein enhances the secretion of glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses
  Kanwal Rehman, Mehwish Bagh Ali, Muhammad Sajid Hamid Akash
  Biomedicine & Pharmacotherapy.2019; 112: 108670.     CrossRef
• Liraglutide vs Exenatide: Patient Adherence, Medication Persistence and Economic Evaluation in the Treatment of Type 2 Diabetes Mellitus
  Fiorenzo Santoleri, Paola Sorice, Ruggero Lasala, Alberto Costantini
  Pharmacology & Pharmacy.2014; 05(04): 332.     CrossRef
• Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling
  Mi-Hyun Kim, Jae-Hwan Jee, Sunyoung Park, Myung-Shik Lee, Kwang-Won Kim, Moon-Kyu Lee
  Journal of Endocrinology.2014; 220(2): 117.     CrossRef
• Predicting the DPP-IV Inhibitory ActivitypIC50Based on Their Physicochemical Properties
  Tianhong Gu, Xiaoyan Yang, Minjie Li, Milin Wu, Qiang Su, Wencong Lu, Yuhui Zhang
  BioMed Research International.2013; 2013: 1.     CrossRef
• Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis
  Ju-Young Kim, Dong-Mee Lim, Hyung-Seo Park, Chan-Il Moon, Kyung-Jin Choi, Seong-Kyu Lee, Haing-Woon Baik, Keun-Young Park, Byung-Joon Kim
  Journal of Pharmacological Sciences.2012; 118(1): 65.     CrossRef
• Retrospective Analysis on the Efficacy, Safety and Treatment Failure Group of Sitagliptin for Mean 10-Month Duration
  Won Jun Kim, Cheol-Young Park, Eun Haeng Jeong, Jeong Youn Seo, Ji Soo Seol, Se Eun Park, Eun Jung Rhee, Won Young Lee, Ki Won Oh, Sung Woo Park, Sun Woo Kim
  Diabetes & Metabolism Journal.2011; 35(3): 290.     CrossRef